Zopiclone Safety in Borderline QTc Prolongation

Understanding Borderline QTc Risk

• Borderline QTc is defined as 440-470 ms, representing a "grey zone" with considerable overlap between affected and unaffected individuals, according to the American College of Cardiology 1
• QTc >500 ms or an increase >60 ms from baseline significantly increases the risk of torsades de pointes, a potentially fatal ventricular arrhythmia, as stated by the American College of Cardiology 2, 1

Why Zopiclone Poses Concern

• QT-prolonging medications should not be used in patients with long QT syndrome or borderline prolongation unless there is no suitable alternative, as recommended by the American College of Cardiology 2
• When QT-prolonging drugs must be used, careful monitoring of the QTc during therapy is recommended, with consideration for discontinuing therapy with marked QTc prolongation, according to the American College of Cardiology 2

Pre-Treatment Assessment Required

• Obtain a baseline ECG using Fridericia's correction formula, as preferred by the American College of Cardiology 1
• Check and correct serum electrolytes, particularly potassium and magnesium, as hypokalemia and hypomagnesemia are strongly associated with QTc prolongation, as stated by the American College of Cardiology 1

Monitoring Strategy If Zopiclone Must Be Used

• Obtain ECG at baseline, 7 days after initiation, and with any dose adjustments, as recommended by the American College of Cardiology 1
• Monitor for symptoms of arrhythmia, including palpitations, syncope, presyncope, or dizziness, according to the American College of Cardiology 4, 3

Safer Alternatives to Consider

• Non-pharmacological interventions for insomnia, such as cognitive behavioral therapy for insomnia, should be considered as first-line approaches, as recommended by the American College of Cardiology 1
• Medications with lower or no QT-prolonging potential should be considered if pharmacotherapy is required, according to the American College of Cardiology 1

Special Population Considerations

• Female patients are at inherently higher risk for drug-induced QTc prolongation and warrant heightened vigilance, as stated by the American College of Cardiology 1
• Elderly patients (>60-65 years) represent an independent risk factor for drug-induced QT prolongation, according to the American College of Cardiology 1